pHetalSafe is a pioneering startup with the mission of advancing fetal monitoring during labor and delivery to ensure safer childbirth. The company's innovative approach harnesses the potential of biophotonics to develop a ground-breaking solution capable of measuring fetal lactate & pH in real-time, enabling an objective assessment of fetal distress and suspected fetal hypoxia during childbirth.
Operating in the Medical Devices sector, pHetalSafe has garnered significant support, including a grant investment secured on 13 March 2023 from Enterprise Ireland. This backing underscores the potential and promise that the startup holds in addressing critical needs within the maternal healthcare space.
No recent news or press coverage available for pHetalSafe.